Bioactive substances with preventive effect in cardiovascular diseases;Sustancias bioactivas con efecto preventivo en la enfermedad cardiovascular

Nutricion Hospitalaria

Volumn 32, Issue 4, 2015, Pages 1462-1467

  Mulero, Juana ^a   Abellán, José ^a   Zafrilla, Pilar ^a   Amores, Diego ^a   Sánchez, Pilar Hernández ^a  

^a CATHOLIC UNIVERSITY OF MURCIA   (Spain)

Author keywords

Anthocyanidins; Anthocyanins; Cardiovascular disease; Catechins; Omega 3; Resveratrol

Indexed keywords

FLAVONOID; OMEGA 3 FATTY ACID;

CARDIOVASCULAR DISEASES; DIET; FUNCTIONAL FOOD; HUMAN; MEDITERRANEAN DIET;

CARDIOVASCULAR DISEASES; DIET; DIET, MEDITERRANEAN; FATTY ACIDS, OMEGA-3; FLAVONOIDS; FUNCTIONAL FOOD; HUMANS;

EID: 84943230117     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.32.4.9510     Document Type: Article

References (60)

1. Hasler, CM. Functional foods: benefits, concerns and challenges-A position paper from the American Council on Science and health. J Nutr 2002; 132: 3772-3781
2. American Heart Association Science Advisory: Phytochemicals and cardiovascular disease. Circulation 1997; 95: 2591-2593.
3. de Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC. Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem 2000;48:5331-7.
4. St. Leger AS, Cochrane AL, Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consuption of wine. The Lancet. 1979; 10: 17-20.
5. Tamba Y, Ohba S, Kubota M, Yoshioka H, Yoshioka H, Yamazaki M. Single GUV Method Reveals Interaction of Tea Catechin (-)-Epigallocatechin Gallate with Lipid Membranes. Biophys J. 2007; 106: 97-105.
6. DalBó S, Goulart S, Horst H, Pizzolatti MG, Ribeiro-do-Valle RM. Activation of endothelial nitric oxide synthase by proanthocyanidin-rich fraction from Croton celtidifolius (Euphorbiaceae): involvement of extracellular calcium influx in rat thoracic aorta. J Pharmacol Sci. 2008; 107:181-9.
7. Vitseva O, Varghese S, Chakrabarti S, Folts JD, Freedman JE. Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates. J Cardiovasc Pharmacol. 2005; 46:445-51.
8. Terra X, Montagut G, Bustos M, Llopiz N, Ardèvol A, Bladé C, et al. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet. J Nutr Biochem. 2009; 20:210-218.
9. Yamakuchi M, Bao C, Ferlito M, Lowenstein CJ. Epigallocatechin gallate inhibits endothelial exocytosis. Biol Chem. 2008; 389:935-41.
10. Del Bas JM, Ricketts ML, Baiges I, Quesada H, Ardevol A, Salvadó MJ, et al. Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner. Mol Nutr Food Res. 2008; 52:1172-81.
11. Baba S, Natsume M, Yasuda A, Nakamura Y, Tamura T, Osakabe N, et al. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo-and hypercholesterolemic humans after intake of different levels of cocoa powder. J Nutr. 2007; 137:1436-41.
12. Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res. 2003; 523-524:87-97.
13. Clifton P. Effect of grape seed extract on cardiovascular and endothelial parameters in high risk subjects. Food Australia. 2003; 55:U9-U12.
14. Aldini G, Carini M, Piccoli A, Rossoni G, Facino RM. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci. 2003; 73:2883-98.
15. Kang WS, Chung KH, Chung JH, Lee JY, Park JB, Zhang YH, et al. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol. 2001;38:875-84.
16. García-Viguera C, Moreno DA, Gil-Izquierdo A, Carvajal M. (Guest Eds.). Bioactive phytochemicals: Connecting farm and health. Phytochem. Rev. 2008; 2: 211-384.
17. Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004; 23:423-33.
18. Naruszewicz M, Laniewska I, Millo B, Duzniewski M. Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infarction (MI). Atherosclerosis. 2007; 194: 179-84.
19. Demrow HS, Sllane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995; 91:1182-8.
20. Karlsen A, Retterstol L, Laake P, Paur I, Kjolsrud-Bohn S, Sandvik L, et al. Anthocyanins inhibit nuclear factor-kB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr. 2007;137:1951-4.
21. García-Alonso M, Rimbach G, Rivas-Gonzalo JC, De Pascual-Teresa S. Antioxidant and cellular activities of anthocyanins and their corresponding vitisins A-studies in platelets, monocytes, and human endothelial cells. J. Agric. Food Chem. 2004; 52: 3378-3384
22. Oak MH, Bedoui JE, Madeira SV, Chalupsky K, Schini-Kerth VB. Delphinidin and cyaniding inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. British J. Pharmacol. 2006; 149: 283-290.
23. Pergola C, Rossi A, Dugo P, Cuzzocrea S, Sautebin L. Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Nitric Oxide-Biol. Chem. 2006; 15: 30-39.
24. Rechner AR, Kroner C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb Res. 2005; 116: 327-334.
25. Young VR. Soy protein in relation to human protein and amino acid nutrition. J. Am. Diet. Assoc. 1991, 91, 828-835.
26. De Kleijn MJJ, Van der Schouw YT, Wilson DEG, Jacques PF. Dietary intake of phytoestrogen is associated with a favorable metabolic cardiovascular risk profile in postmenopausal US women: The Framingham study. J Nutr. 2002; 132: 276-82
27. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr. 1998; 128: 728-32
28. Wiseman H, O'Reilly J, Adlercreutz H, Mallet A, Howey E, Rowland I. Isoflavones phytoestrogen consumed in soy decrease f2-isoprostane concentration and increase resistance of low-density lipoprotein to oxidation in human. Am J Clin Nutr. 2000; 72: 395-400
29. Figree GA, Griffthlis H, Lu Y-Q, Webb CM, MacLeod K, Collins P. Plant derived estrogen relax coronary arteries in vitro by a calcium antagonist mechanism. J Amer Coll Cardiol. 2000; 35: 1977-85.
30. Cuevas, A.M, Irribarra, V.L, Castillo, O.A, Yánez, M.D, Germain, A.M. Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women. Eur J Clin Nutr. 2003; 57: 889-894.
31. Chan YH, Lau KK, Yiu KH, Li SW, Chan HT, Fong DY, et al. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur. Heart J. 2008; 29: 2800-2807.
32. Hwuang J, Wang J, Orazzoni P, Hodis HN, Sevania, A. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: An antioxidante mechamisn for cell-mediated LDL modification. Free Radic Biol Med. 2003; 34: 1271-1282.
33. Jackman KA, Woodman OL, Chrissobolis S, Sobey CG. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries. Brain Res. 2007; 1141: 99-107.
34. Siemann EH, Creasy LL. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Viticult. 1992; 43:49-52.
35. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int. J. Mol. Med. 2005; 16:533-540.
36. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006; 444:337-342.
37. Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275:218-220.
38. Szewczuk LM, Forti L, Stivala LA, Penning TM. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem. 2004; 279:22727-22737.
39. Li HF, Chen SA, Wu SN. Evidence for the stimulatory effect of resveratrol on Ca2+-activated K+ current in vascular endothelial cells. Cardiovasc. 2000; 45; 1035-1045.
40. Das S, Alegappan VK, Bagchi D, Shama HS, Maulik N, Das DK. Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul. Pharmacol. 2005; 42: 281-289.
41. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5:493-506.
42. Marier JF, Chen K, Prince P, Scott G, del Castillo JR, Vachon P. Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner. Can J Vet Res 2005;69(2):151-154
43. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2001; 28:55-59.
44. Meisel H. Overview on milk protein-derived peptides. Int Dairy Journal. 1998; 8:363-73.
45. Darragh AJ. Phsyiological impact of milk protein-encrypted bioactive peptides. Bulletin of the International Dairy Federation. 2002; 375:25-31.
46. Jollès P, Lévy-Toledano S, Fiat AM, Soria C, Gillensen D, Thomaidis A et al. Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from E-casein on platelet function. Europ J Biochem. 1986; 158: 379-82.
47. Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Eur J Biochem. 1990; 194: 43-49.
48. Wyvratt MJ, Patchett AA. Recent developments in the design of angiotensin converting enzyme inhibitors. Med Res Rev. 1985; 5: 485-531.
49. Mulero J, Zafrila P, Martínez-Cachá A, Leal M, Abellán J. Péptidos bioactivos. Clin Invest Arterioscl, 2011, 1-9
50. Kuklinski C. Nutrición y Bromatología. Ediciones Omega; 2003. p.33-34.
51. Cater NB, Garcia-Garcia AB, Vega GL, Grundy SM. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am J Cardiol 2005;96:23-28.
52. Child, P, Kuksis, A. Critical role of ring structure in the differential uptake of colesterol and plant sterols by membrane preparations in vitro. J Lipid Res. 1983; 24: 1196-1209.
53. Plat, J, Mensink, RP. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. Faseb J. 2002; 16: 258-260.
54. Hendriks, HF, Weststrate, JA, van Vliet, T, Meijer, GW. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1999; 53: 319-327.
55. De Jong, A, Plat, J, Mensink, RP. Metabolic effects of plant sterols and stanols (Review). J Nutr Biochem 2003; 14: 362-369.
56. Flickinger B.D, Huth P.J. Dietary fats and oils: technologies for improving cardiovascular health. Curr. Atheroscler. Rep 2004; 6: 468-476.
57. GISI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISI-Prevenzione trial. Lancet. 1999; 99: 779-785.
58. Siscovick D, Raghunathan TE, King I, Weinmann S, Bovbjerg VE, Kushi L. et al. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 2000; 71: 208S-212S.
59. Yaqood P. Lipids and the immune response: from molecular mechanisms to clinical applications. Curr Opin Clin Nutr Metab Care. 2003; 6:133-50.
60. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endotelial activation in women. J Nutr. 2004; 134(7):1806-1811.